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Highlights 
• tert-Butylhydroquinone (TBHQ), a food additive, has therapeutic potential. 
• TBHQ caused hyperpolarization that was followed by depolarization in rat thymocytes. 
• The hyperpolarization was due to the activation of Ca2+-dependent K+ channels. 
• The depolarization was due to a nonspecific increase in membrane ionic permeability. 
• TBHQ-induced changes in membrane potential may be adverse for lymphocytes. 
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Abstract 
     Tertiary butylhydroquinone (TBHQ) is a food additive and has various beneficial actions 
under in vitro and in vivo experimental conditions. Therefore, it is necessary to collect 
additional data on the toxicity of TBHQ in order to avoid adverse effects during clinical 
applications. Changes in plasma membrane potential are associated with changes in 
physiological functions even in non-excitable cells such as lymphocytes. Thus, compounds that 
affect membrane potential may modify some lymphocytic functions. The effect of TBHQ on 
plasma membrane potential was examined in rat thymocytes using flow cytometric techniques. 
Treatment of rat thymocytes with TBHQ caused hyperpolarization and then depolarization. The 
TBHQ-induced hyperpolarization was due to the activation of Ca2+-dependent K+ channels. 
TBHQ elevated intracellular Ca2+ levels. The depolarization by TBHQ was caused by a 
nonspecific increase in membrane ionic permeability. Both the sustained depolarization and 
elevation of intracellular Ca2+ level by TBHQ are thought to be adverse for thymocytes because 
such changes disturb membrane and intracellular signaling. The thymus is most active during 
neonatal and pre-adolescent periods. If TBHQ exerts adverse actions on thymocytes, it may 
result in an immunotoxic effect in neonates and adolescents. 
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1. Introduction 
     Tertiary butylhydroquinone (TBHQ, Chemical Abstracts 1948-33-0) is a food additive 
that has antioxidant activity (World Health Organization, 1999). The European Food Safety 
Authority has evaluated the toxicity of TBHQ and determined safe levels of TBHQ as a food 
additive (European Food Safety Authority, 2004). Antioxidative TBHQ exerts various 
beneficial actions under in vitro and in vivo experimental conditions (Jin et al, 2011; Rosanna 
and Salvatore, 2012; Mittal et al, 2014; Duan et al, 2016) because reactive oxygen species are 
involved in many diseases (Uttara et al., 2009; Briege et al., 2012). Various major diseases such 
as atherosclerosis, arthritis, ischemia, Alzheimer’s, Parkinson’s, diabetes, sclerosis, gastritis, 
aging, liver diseases, cancer and AIDS are due to the generation of free radicals (Halliwell and 
Gutteridge, 1984). Since TBHQ has been already approved as a food additive, it is plausible that 
it will be used as a preventive and/or therapeutic medicinal agent. However, TBHQ also 
exhibits diverse toxic actions under experimental conditions (Imhoff and Hansen, 2010; 
Braeuning et al., 2012; Shibuya et al., 2012; Eskandani et al., 2014). For example, TBHQ 
induces mitochondrial oxidative stress causing Nrf2 activation. The oxidation of TBHQ 
produces more cytotoxic tert-butyl-p-benzoquinone. Therefore, it is necessary to collect 
additional data on the toxicity of TBHQ in order to avoid adverse actions during medical 
applications.  
     Plasma membrane potential is determined by membrane ionic permeability and 
transmembrane ionic gradient. Both are modulated by various physiological, pharmacological, 
and toxicological factors. The ionic gradient across membranes is maintained by the functional 
integration of cellular energy metabolism and a membrane with selective permeability. Changes 
in membrane potential are associated with altered physiological functions even in non-excitable 
cells, such as lymphocytes (Tsien et al., 1982; Han and Kang, 2009; Varga et al., 2010; Lam and 
Wulff, 2011; Feske et al., 2012). Opening and closing of K+ channels change membrane K+ 
permeability, one of the important determinants of membrane potential. Charybdotoxin, a 
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specific blocker of Ca2+-dependent K+ channels (Miller et al., 1985), inhibits the proliferation of 
T lymphocytes (Price et al., 1989). Non-specific blockers of K+ channels inhibit the activation 
of B lymphocytes, resulting in an attenuation of lymphocytic progression through the cell cycle 
(Amigorena et al., 1990). Furthermore, the activity of phosphoinositide phosphatase is tuned 
within physiological range of plasma membrane potential (Murata et al., 2005). Thus, 
membrane potential can function beyond channel proteins. Based on the evidence, it is likely 
that the compounds that affect membrane potentials modify some functions in lymphocytes. 
     In this study, we examined the effect of TBHQ on the plasma membrane potential in rat 
thymocytes. Voltages were assessed using a voltage-sensitive fluorescent dye and the cells were 
studied using flow-cytometry, which revealed the mechanisms of TBHQ-induced changes in 
plasma membrane potential. One may argue that membrane potential is not a target for the 
adverse effects of food additives, including preservatives. However, the depolarization 
modulates plasma membrane phospholipid dynamics and K-Ras signaling in fibroblasts, 
excitable neuroblastoma cells, and Drosophila neurons (Zhou et al., 2015). Thus, the changes in 
membrane potentials seem to affect membrane and cellular functions. Furthermore, the thymus 
is most active during neonatal and pre-adolescent periods. Since there is a major concern about 
the adverse effect of food additives on children's health, any adverse change in thymocytes may 
be clinically important.  
      
2. Materials and methods 
2.1. Chemicals 
     TBHQ (99.1% purity) was purchased from Tokyo Chemical Ind. (Tokyo, Japan). bis-
(1,3-Dibutylbarbituric acid)trimethine oxonol (Oxonol), Fluo-3-AM, and propidium iodide (PI) 
were supplied by Invitrogen (Eugene, OR, USA). Chelators for extracellular Ca2+ and 
intracellular Zn2+ were, respectively, disodium salt of ethylenediamine-N,N,N',N'-tetraacetic 
acid and N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (EDTA and TPEN; Dojindo 
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Molecular Technologies, Inc., Kumamoto, Japan). Unless mentioned, all other reagents were 
obtained from Wako Pure Chemicals (Osaka, Japan). 
2.2. Cell preparation 
     Experiments were performed under the approval (No. 05279) of Tokushima University 
Committee for Animal Experiments. Thymus glands were obtained from 6–8 week old Wistar 
rats that were anesthetized with ether. To dissociate individual cells, the glands were triturated 
in chilled Tyrode's solution (2–4 °C). The solution containing dissociated cells (cell suspension) 
was incubated at 36–37 °C for 1 h before experiments. The cell suspension contained trace 
amounts (216.9 ± 14.4 nM) of zinc from the cell preparation.  
     Thymocytes were used for this study of chemical cytotoxicity due to the following 
experimental reasons. First, single dissociated cells with intact membranes are easily obtained 
since no enzymatic treatment is required to isolate individual cells. Second, several types of 
chemical and biological substances induce cell death (Corsini et al., 2013; Kuchler et al., 2014). 
Third, the process of cell death (apoptosis, necrosis, and autophagy) is well studied (Klein, 
Kyewski et al., 2014; Poon et al., 2014; Shimizu, et al., 2014). However, there is an 
experimental limitation for dissociated thymocytes. Thymocytes spontaneously undergo 
apoptosis during prolonged incubation. All experiments, therefore, including the preparation of 
the cell suspension, were completed within 8 h after the dissection of thymus from rats to avoid 
possible contribution of spontaneous apoptosis. Therefore, the time for TBHQ treatment should 
be less than 5 h. Cell shrinkage is one of parameters observed during an early stage of apoptosis. 
We employed forward scatter as a parameter of cell size. The intensity of forward scatter in 
control cells was not changed during the experiment. The cell viability of control cells was also 
unchanged during the experiment. 
     TBHQ (10–300 mM in 2 µL dimethyl sulfoxide) was added to 2 mL of cell suspension to 
achieve final concentrations of 10–300 µM, and the cells were treated with TBHQ for 1–4 h, 
depending on respective experimental procedures. A sample (100 µL) from each cell suspension 
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was analyzed by flow cytometry. Data acquisition from 2000–2500 cells took approximately 
10–15 s. The sheath flow rate was manually adjusted to measure 195–205 cells/s with an 
interval of 180 µs between measurements of forward and side scatters. The measurement started 
after achieving a constant flow of cells. Cell lethality estimated from 2500 cells was quite 
similar to that estimated from 10000 cells. Therefore, 2500 cells were deemed sufficient to 
examine cellular actions of TBHQ. 
2.3. Fluorescence measurement 
     Fluorescence was measured and analyzed using a flow cytometer (CytoACE-150; JASCO, 
Tokyo, Japan) and JASCO software package (Chikahisa et al., 1996). Chemical reagents, except 
for fluorescent probes, exhibited no fluorescence under the experimental conditions used. PI (5 
µM), a fluorescent probe that stains the DNA of dead cells, was added to the cell suspension to 
assess cell lethality. Measurements of membrane potentials were made using 500 nM Oxonol. 
Cells were incubated with 1 µM Fluo-3-AM for 50–60 min before fluorescence measurement in 
order to monitor the change in [Ca2+]i (Kao et al., 1989). Fluo-3 fluorescence was monitored in 
the cells treated with 10 µM TPEN to avoid the contribution of intracellular Zn2+ to Fluo-3 
fluorescence. Oxonol and Fluo-3 fluorescence were monitored in cells that did not show PI 
fluorescence (living cells with intact membranes). The excitation wavelength for fluorescent 
probes was 488 nm, and emissions were detected at 530 ± 20 nm for Oxonol and Fluo-3 
fluorescence, and at 600 ± 20 nm for PI fluorescence. Oxonol and Fluo-3-AM were dissolved in 
DMSO. Therefore, control cell suspension contained 0.1 % DMSO. The intensities of Oxonol 
and Fluo-3 fluorescence in control cells were similar to those observed in cell suspension 
containing 0.3 % DMSO. Cell viability of the suspension containing 0.1 % DMSO was also 
similar to that of cell suspension containing 0.3 % DMSO. Thus, DMSO (up to 0.3 %) did not 
affect cellular parameters examined in this study. 
2.4. Statistical analysis and presentation 
     Statistical analysis was carried out using Tukey's multivariate analysis. P-values of < 0.05 
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indicate statistical significance. Values are expressed as mean and standard deviation of 4–8 
samples. Each experimental series was conducted three times unless stated otherwise.  
 
3. Results 
3.1. Changes in oxonol fluorescence by TBHQ 
     TBHQ at a concentration of 300 µM decreased the intensity of Oxonol fluorescence 
immediately after application, which was maintained for 30–60 min (Fig. 1A). An augmentation 
was observed at 90 min after the start of application (Fig. 1A). Although the attenuation of 
Oxonol fluorescence always preceded the augmentation in the presence of 300 µM TBHQ, the 
time course of TBHQ-induced differs slightly between cells obtained from different animals. A 
similar attenuation of Oxonol fluorescence was also observed after the start of treatment with 
100 nM A23187, a calcium ionophore (Fig. 1B). Results are summarized in Fig. 1C. The 
attenuation of Oxonol fluorescence by 100 µM TBHQ continued for 90 min after the 
application (not shown). 
 (Figure 1 near here) 
3.2. Effect of CTX on TBHQ-induced changes in Oxonol fluorescence 
     Since the time course of TBHQ-induced change in Oxonol fluorescence varied between 
the cells obtained from different rats, the experiments described below were performed with the 
cells where the Oxonol fluorescence was significantly attenuated 60 min after the start of TBHQ 
application under normal Ca2+ conditions. This attenuation was dose-dependent, as can be seen 
in Figure 2A.  
     The attenuation of Oxonol fluorescence by 100–300 µM TBHQ and 100 nM A23187 was 
statistically significant. A23187 activates the Ca2+-dependent K+ channels found in the rat 
thymocytes (Wilson and Chused, 1985) by increasing [Ca2+]i, resulting in the attenuation of 
Oxonol fluorescence. CTX specifically inhibits Ca2+-dependent K+ channels (Miller et al., 1985). 
Therefore, the effect of 300 nM CTX on TBHQ-induced attenuation of Oxonol fluorescence 
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was examined to determine whether Ca2+-dependent K+ channels are involved in the response of 
TBHQ. CTX completely suppressed the attenuation of Oxonol fluorescence by 100 µM TBHQ 
(Fig. 2B). Indeed, in the presence of CTX, 300 µM TBHQ induced the augmentation of Oxonol 
fluorescence (Fig. 2B). Thus, CTX reversed the effect of 300 µM TBHQ, and significantly 
lessened the attenuation of Oxonol fluorescence induced by A23187 (Fig. 2B).  
(Figure 2 near here) 
3.3. TBHQ-induced changes in Oxonol fluorescence under external Ca2+-free conditions 
     From the result shown in Fig. 2B, TBHQ increased the [Ca2+]i via Ca2+ influx, resulting in 
the activation of the Ca2+-dependent K+ channels. Therefore, the effects of TBHQ on Oxonol 
fluorescence were examined under external Ca2+-free conditions. TBHQ at 100–300 µM 
significantly augmented the Oxonol fluorescence under external Ca2+-free conditions (Fig. 2C). 
The removal of external Ca2+ reversed the TBHQ-induced responses. The attenuation of Oxonol 
fluorescence by A23187 under external Ca2+-free conditions (Fig. 2C) was significantly smaller 
than that in the presence of external Ca2+ (Fig. 2A).  
3.4. Changes in Fluo-3 fluorescence by TBHQ 
     The result shown in Fig. 2B and C suggested that Ca2+ was involved in the TBHQ-
induced attenuation of Oxonol fluorescence. The effect of TBHQ on Fluo-3 fluorescence was 
examined to determine whether an increase in [Ca2+]i was involved. The treatments of cells with 
100–300 µM TBHQ for 60 min shifted the histogram of Fluo-3 fluorescence in a direction of 
higher intensity (Fig. 3A). The augmentation of Fluo-3 fluorescence by TBHQ at 30–300 µM 
was observed to be concentration-dependent (Fig. 3B). The augmentation of Fluo-3 
fluorescence by 100–300 µM TBHQ was statistically significant. The augmentation by 100 nM 
A23187 was greater than that by TBHQ. 
(Figure 3 near here) 
3.5. TBHQ-induced changes in Fluo-3 fluorescence under external Ca2+-free conditions 
     To determine whether external Ca2+ is involved in the TBHQ-induced augmentation of 
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Fluo-3 fluorescence, the effects of 100–300 µM TBHQ on Fluo-3 fluorescence were examined 
under external Ca2+-free conditions. The cells were treated with TBHQ for 60 min under 
external Ca2+-free conditions. The augmentation of Fluo-3 fluorescence by TBHQ was 
completely suppressed under external Ca2+-free conditions (Fig. 4A), indicating an involvement 
of external Ca2+. Removal of external Ca2+ also greatly diminished the A23187-induced 
augmentation of Fluo-3 fluorescence (Fig. 4A).  
(Figure 4 near here) 
3.6. Mn2+-induced quenching of Fluo-3 fluorescence in the presence of TBHQ 
     The result shown in Fig. 4A suggested that TBHQ increased membrane permeability to 
Ca2+, resulting in an increase in [Ca2+]i. To test this hypothesis, the cells were simultaneously 
treated with 300 µM TBHQ and 2 mM Mn2+ for 60 min under normal Ca2+ conditions. TBHQ 
itself augmented Fluo-3 fluorescence, while TBHQ and Mn2+ attenuated Fluo-3 fluorescence 
(Fig. 4B). Thus, we suggest that Mn2+ passes through membranes of cells treated with TBHQ, 
resulting in Mn2+-induced quenching of Fluo-3 fluorescence. 
 
4. Discussion 
4.1. TBHQ-induced changes in membrane potential and [Ca2+]i 
     The attenuation and augmentation of Oxonol fluorescence indicate hyperpolarization and 
depolarization, respectively (Rink et al., 1980). Treatment of rat thymocytes with TBHQ 
initially induced hyperpolarization and thereafter depolarization. The fact that CTX inhibited 
TBHQ-induced hyperpolarization suggests that TBHQ activates Ca2+-dependent K+ channels, 
which increases membrane K+ permeability. TBHQ (300 µM) depolarized the membranes in the 
presence of CTX and under external Ca2+-free conditions. Thus, TBHQ is assumed to have a 
hyperpolarizing action via activation of Ca2+-dependent K+ channels and depolarizing action. 
Therefore, the time course of change in membrane potential of cells treated with TBHQ may be 
determined by the balance of hyperpolarizing and depolarizing actions. The depolarizing action 
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by TBHQ was caused by a nonspecific increase in membrane ionic permeability, as seen when 
Mn2+ passed through the membranes of cells treated with TBHQ. In the absence of TBHQ, 
however, treatment of cells with 2 mM Mn2+ for 60 min did not affect Fluo-3 fluorescence, 
suggesting that Mn2+ did not pass through the membranes (Fig4A). It is important to note that 
depolarization can also be caused by a decrease in resting membrane K+ permeability. Therefore, 
it is possible that TBHQ possesses an inhibitory action on resting membrane K+ permeability. 
      The attenuation and augmentation of Fluo-3 fluorescence indicate a decrease and an 
increase in the [Ca2+]i, respectively (Kao et al., 1989). TBHQ at concentrations of 100–300 µM 
significantly elevated the [Ca2+]i in rat thymocytes by increasing the membrane permeability to 
Ca2+, resulting in an influx of external Ca2+ along with transmembrane Ca2+ gradient. This 
mechanism is supported by the observation that the removal of external Ca2+ completely 
diminished the TBHQ-induced increase in [Ca2+]i. As described above, it was observed that 
Mn2+ passed through the membranes in the presence of TBHQ. Thus, the sustained treatment of 
cells with TBHQ may non-specifically increase membrane ionic permeability. The increase in 
[Ca2+]i in the presence of TBHQ may be much adverseer than the TBHQ-induced change in 
membrane potential, since intracellular Ca2+ is involved in many physiological functions and the 
dyshomeostasis of intracellular Ca2+ disturbs many intracellular signaling pathways (Berridge et 
al., 1998). Thus, the sustained increase in [Ca2+]i by TBHQ is linked to cell injury and cell death.  
4.2. Implications 
     The change in membrane potential of lymphocytes is associated with physiological 
changes. Early studies showed that CTX, a specific inhibitor of Ca2+-dependent K+ channels, 
blocked the proliferation of T lymphocytes (Price et al., 1989). Selective immunomodulatory 
action is expected in the agents possessing inhibitory actions on voltage-dependent and Ca2+-
dependent K+ channels in recent studies (Han and Kang, 2009; Varga et al., 2010; Lam and 
Wulff, 2011; Feske et al., 2012). Under control conditions in the presence of TBHQ, the 
original hyperpolarization was followed by the consistent depolarization. T-cell mitogens cause 
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changes in membrane potential and [Ca2+]i (Tsien et al., 1982). Such changes can be disturbed 
by TBHQ. Thus, it may be unlikely that the mitogens cause cellular signalings of lymphocytes 
in the presence of TBHQ. Furthermore, as shown in the histogram of Figs. 1A and 3A, all cells 
responded to TBHQ. Therefore, the actions of TBHQ were independent from the cell types that 
were immunologically classified. 
     The Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in 
Contact with Food was asked to advise on the safety in use of TBHQ in fats and oils used for 
human consumption (2004). TBHQ is used at a level of up to 200 mg/kg fat or oil. The Panel 
also considers the dog as the most sensitive species and allocated an acceptable daily intake of 
0.7 mg/kg based on a no-observed-adverse-effect-level (NOAEL) of 72 mg/kg body weight per 
day in dogs to which a 100-fold safety factor was applied. If basal metabolic rate per one day in 
male adult (50 kg) is 3000 Kcal, 100 g of fat would be required when 30 % of basal metabolic 
rate is covered with fat intake. 100 g of edible oils contains 20 mg TBHQ at maximum. Even 
under the assumption that all BHT in edible oils (0.4 mg/kg body weight) is absorbed, it would 
be unlikely that the blood concentration of BHT reaches 30–100 µM. Thus, the daily intake of 
BHT under FDA regulations is safe. The European Food Safety Authority (2016) estimates the 
95% percentile exposure to TBHQ as a food additive to be 0.009–0.555 mg/kg body weight/day 
in infants (4–11 months), 0.084–0.798 mg/kg body weight/day in toddlers (12–35 months), 
0.116–0.929 mg/kg body weight/day in children (3–9 years), and 0.040–0.420 mg/kg body 
weight/day in adolescents (10–17 years). It may be something unrealistic to predict blood 
concentration of TBHQ based only on oral ingestion. It is unlikely that TBHQ at concentrations 
used as a food additive affects thymocytes of infants and/or children since the minimum in vitro 
concentration of TBHQ needed to change the thymocyte membrane potential and [Ca2+]i was 
30–100 µM (4.9–16.6 mg/L).  
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Figure legends 
 
Figure 1. Changes in Oxonol fluorescence after the addition of 300 µM Tert-butylhydroquinone 
(TBHQ) and 100 nM A23187. (A) TBHQ-induced shift of Oxonol fluorescence histogram. 
Histograms, consisting of 2500 mouse thymocyte cells, were obtained 60 min and 90 min after 
the start of TBHQ application. (B) The shift of the fluorescence histogram by TBHQ and 
A23187. The histogram was obtained at 60 min after the start of application. (C) Changes in the 
mean Oxonol fluorescence intensity in cells treated with TBHQ or A23187. Column and bar 
indicate mean and standard deviation of four samples. Dotted line indicates control level. 
Asterisks (**) show significant difference between control group and TBHQ or A23187 groups.  
 
Figure 2. Tert-butylhydroquinone (TBHQ)-induced attenuation of Oxonol fluorescence in 
mouse thymocytes. (A) A concentration-dependent decrease in the mean intensity of Oxonol 
fluorescence is seen after the application of 30–300 µM TBHQ. A23187 was used as a reference 
drug. (B) The effects of TBHQ and A23187 in presence of 300 nM charybdotoxin. (C) The 
effects of TBHQ and A23187 under external Ca2+-free conditions. The results of (A)–(C) were 
obtained from the samples dispensed from same cell suspensions. Effects were examined at 60 
min after the start of drug application. The dotted line shows respective control level. The 
column and bar indicate mean and standard deviation of four samples. Asterisks (**) show 
significant differences between the control group and groups of cells treated with TBHQ or 
A23187 under respective experimental conditions.  
 
Figure 3. Changes in Fluo-3 fluorescence in rat thymocytes after the application of Tert-
butylhydroquinone (TBHQ) and A23187. (A) Shift of Fluo-3 fluorescence histogram due to 
application of 100–300 µM TBHQ. Histogram consisted of 2500 cells. The effect was examined 
60 min after the start of drug application. (B) A concentration-dependent increase in the mean 
–19– 
intensity of Fluo-3 fluorescence was observed after the application of 30–300 µM TBHQ. 
A23187 was used as a reference drug, and the dotted line shows the fluorescence level of the 
control group. The column and bar indicate the mean and standard deviation of four samples. 
Asterisks (**) show a significant difference between the control group and TBHQ or A23187 
groups under respective experimental conditions.  
 
Figure 4. Tert-butylhydroquinone (TBHQ)-induced augmentation of Fluo-3 fluorescence. (A) 
The effect of 100–300 µM TBHQ and 100 nM A23187 under external Ca2+-free conditions. (B) 
The effect of 300 µM TBHQ in the presence of 2 mM MnCl2. Effects were examined 60 min 
after the start of the drug application. The dotted line shows the fluorescence of the control 
sample. The column and bar indicate the mean and standard deviation of four samples. Asterisks 
(**) show a significant difference between the control group and TBHQ or A23187 groups 
under respective experimental conditions.  
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